Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) Long Term Investor Alert: Investigation Announced
An investigation for current long-term investors in shares of Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) over potential wrongdoing by certain officers and directors of Progenics Pharmaceuticals was announced and current long-term NASDAQ:PGNX stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com
View full press release